• Home
  • Media Events
  • Hematology Expert Illuminates Advances in Coagulation Science

Hematology Expert Illuminates Advances in Coagulation Science

Published on: August 10, 2024

The Department of Pathology at Swami Rama Himalayan University hosted a guest lecture by Dr. (Col) Jyoti Kotwal, a renowned hematologist from Sir Ganga Ram Hospital, New Delhi, on August 10, 2024. Dr. Kotwal, also serving as the President of the Delhi Society of Haematology, delivered an insightful session titled “Hematology Insights: From Coagulation to Cytometry.”

Addressing an audience of around 120 delegates, Dr. Kotwal shared her vast clinical expertise in coagulation diagnostics and management. Her lecture focused on the critical role of D-dimer testing, a key biomarker in assessing fibrin degradation and evaluating the duration of anticoagulation therapy, especially in cases of unprovoked venous thromboembolism (VTE).

A significant highlight of her talk was the emphasis on the timing of thrombophilia testing to avoid misleading results. She urged clinicians to opt for comprehensive thrombophilia panels and appropriate diagnostic assays when dealing with complex conditions such as antiphospholipid syndrome.

In a particularly relevant segment, Dr. Kotwal discussed the heightened risk of thrombosis among individuals at high altitudes, such as Indian soldiers. She explained how increased hemoglobin concentration, platelet activation, and elevated PAI-1 levels collectively contribute to a hypercoagulable state in such settings. This underscores the need for context-specific therapeutic approaches.

Dr. Kotwal advocated for personalized anticoagulation strategies, noting that a one-size-fits-all model does not always prevent thrombosis or bleeding complications in patients with diverse clinical profiles.

The guest lecture was met with enthusiastic participation and thoughtful engagement from attendees. It served as a valuable opportunity for postgraduate students, faculty, and clinicians to deepen their understanding of hematological disorders and evolving diagnostic tools.

The session concluded with a lively Q&A segment and a vote of thanks, marking a day of enriched academic discourse and practical learning.

Picture1
   Admissions Form         

Admission Open For 2025

×
International Endowed Chair Professor

Prof Rakesh Kumar

Prof Rakesh Kumar is the Founder and President of the Breast Cancer in Young Women Foundation (USA), dedicated to vaddressing the distinct issues affecting young women with breast cancer. He also serves as the International Endowed Chair Professor at the Cancer Research Institute of the Himalayan Institute of Medical Sciences. Additionally, he holds adjunct professorships at Rutgers New Jersey Medical School and Virginia Commonwealth University.

Dr Kumar earned his Ph.D. from the All India Institute of Medical Sciences in 1984 and began his research career at Memorial Sloan Kettering Cancer Center in January 1986. From 1988 to 2017, he held various academic and leadership positions —including faculty member, tenured professor, distinguished professor, endowed chair, department chair, and research leader—at esteemed institutions such as Memorial Sloan Kettering Cancer Center in New York and the University of Texas MD Anderson Cancer Center in Houston. From 2017 to 2022, he served as the National Chair for Cancer Research for the Government of India and as a distinguished professor, continuing his innovative work in breast cancer research.

With nearly 40 years of research and professional experience, Dr. Kumar has made conceptual contributions to the field of cancer research (h-index 108, citations >50,000). He has authored over 325 peer-reviewed publications, edited or co-edited nine books, and delivered 290 invited lectures worldwide. His work has been featured on the covers of 18 major cancer journals and has been highlighted in institutional research reports of the MD Anderson Cancer Center.

A passionate educator and mentor, Dr. Kumar has guided 67 trainees throughout his career. He serves on the editorial boards of multiple leading cancer journals and has served on the editorial boards of 21 top cancer journals. His global reputation is further demonstrated by his participation in about 100 peer-review panels for cancer research funding in the US and internationally over the past 28 years.

Dr. Kumar's innovative research has earned him numerous prestigious honors, including the Hinkle Society Faculty Award at Penn State University (1994), the Dalla/Fort Worth Living Legend Faculty Achievement Award in Basic Sciences (2004), the Ranbaxy Research Award (2006), and the Lifetime Achievement Award from the American Association of Indian Scientists in Cancer Research (2013), among others. Dr. Kumar's pioneering research continues to have a profound influence on the fields of oncology and breast cancer, opening up new opportunities for biomedical scientists and trainees worldwide.